Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model

Neuropharmacology

Volumn 64, Issue , 2013, Pages 414-423

  Whittle, Nigel ^a   Schmuckermair, Claudia ^a   Gunduz Cinar, Ozge ^b,c   Hauschild, Markus ^a   Ferraguti, Francesco ^a   Holmes, Andrew ^b,c   Singewald, Nicolas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Epigenetics; Fear extinction; HDAC inhibitor; Metabotropic glutamate receptor; NMDA receptor; Ventral striatum deep brain stimulation

Indexed keywords

AMN 082; AMPA RECEPTOR AGONIST; ENTINOSTAT; HISTONE DEACETYLASE; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR AGONIST; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; ENZYME INHIBITION; FEAR; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REINFORCEMENT; TREATMENT OUTCOME;

EID: 84866368797     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.06.001     Document Type: Article

References (109)

1. I. Akirav, H. Raizel, and M. Maroun Enhancement of conditioned fear extinction by infusion of the GABA agonist muscimol into the rat prefrontal cortex and amygdala Eur. J. Neurosci. 23 2006 758 764
2. M. Baetz, and R.C. Bowen Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy Can. J. Psychiatry Revue canadienne de psychiatrie 43 1998 73 77
3. S. Bahari-Javan, A. Maddalena, C. Kerimoglu, J. Wittnam, T. Held, M. Bahr, S. Burkhardt, I. Delalle, S. Kugler, A. Fischer, and F. Sananbenesi HDAC1 regulates fear extinction in mice J. Neurosci. 32 2012 5062 5073
4. M. Bantscheff, C. Hopf, M.M. Savitski, A. Dittmann, P. Grandi, A.M. Michon, J. Schlegl, Y. Abraham, I. Becher, G. Bergamini, M. Boesche, M. Delling, B. Dumpelfeld, D. Eberhard, C. Huthmacher, T. Mathieson, D. Poeckel, V. Reader, K. Strunk, G. Sweetman, U. Kruse, G. Neubauer, N.G. Ramsden, and G. Drewes Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes Nat. Biotechnol. 29 2011 255 265
5. D.H. Barlow, J.M. Gorman, M.K. Shear, and S.W. Woods Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial JAMA 283 2000 2529 2536
6. B.H. Bewernick, S. Kayser, V. Sturm, and T.E. Schlaepfer Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy Neuropsychopharmacology 37 2012 1975 1985
7. R.J. Blanchard, and D.C. Blanchard Crouching as an index of fear J. Comp. Physiol. Psychol. 67 1969 370 375
8. O. Bousiges, A.P. Vasconcelos, R. Neidl, B. Cosquer, K. Herbeaux, I. Panteleeva, J.P. Loeffler, J.C. Cassel, and A.L. Boutillier Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus Neuropsychopharmacology 35 2010 2521 2537
9. T.W. Bredy, and M. Barad The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear Learn. Mem. 15 2008 39 45
10. T.W. Bredy, H. Wu, C. Crego, J. Zellhoefer, Y.E. Sun, and M. Barad Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear Learn. Mem. 14 2007 268 276
11. A. Burdick, W.K. Goodman, and K.D. Foote Deep brain stimulation for refractory obsessive-compulsive disorder Front. Biosci.: a Journal and Virtual Library 14 2009 1880 1890
12. M. Camp, M. Norcross, N. Whittle, M. Feyder, W. D'Hanis, D. Yilmazer-Hanke, N. Singewald, and A. Holmes Impaired Pavlovian fear extinction is a common phenotype across genetic lineages of the 129 inbred mouse strain Genes Brain Behav. 8 2009 744 752
13. M. Camp, K.P. MacPherson, L. Lederle, C. Graybeal, S. Gaburro, L.M. Debrouse, J.L. Ihne, J.A. Bravo, R.M. O'Connor, S. Ciocchi, C.L. Wellman, A. Luthi, J.F. Cryan, N. Singewald, and A. Holmes Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes Neuropsychopharmacology 2012 10.1038/npp.2011.1340
14. J.P. Chhatwal, M. Davis, K.A. Maguschak, and K.J. Ressler Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear Neuropsychopharmacology 30 2005 516 524
15. J.P. Chhatwal, L. Stanek-Rattiner, M. Davis, and K.J. Ressler Amygdala BDNF signaling is required for consolidation but not encoding of extinction Nat. Neurosci. 9 2006 870 872
16. G. Cora-Locatelli, B.D. Greenberg, J.D. Martin, and D.L. Murphy Valproate monotherapy in an SRI-intolerant OCD patient J. Clin. Psychiatry 59 1998 82
17. G.L. Dalton, D.C. Wu, Y.T. Wang, S.B. Floresco, and A.G. Phillips NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear Neuropharmacology 62 2012 797 806
18. P.K. Dash, S.A. Orsi, and A.N. Moore Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury Neuroscience 163 2009 1 8
19. J.R. Davidson, E.B. Foa, J.D. Huppert, F.J. Keefe, M.E. Franklin, J.S. Compton, N. Zhao, K.M. Connor, T.R. Lynch, and K.M. Gadde Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia Arch. Gen. Psychiatry 61 2004 1005 1013
20. M. Davis, K. Ressler, B.O. Rothbaum, and R. Richardson Effects of D-cycloserine on extinction: translation from preclinical to clinical work Biol. Psychiatry 60 2006 369 375
21. L.L. Davis, J.R. Davidson, L.C. Ward, A. Bartolucci, C.L. Bowden, and F. Petty Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population J. Clin. Psychopharmacol. 28 2008 84 88
22. M. Davis NMDA receptors and fear extinction: implications for cognitive behavioral therapy Dialogues Clin. Neurosci. 13 2011 463 474
23. M. Fendt, S. Schmid, D.R. Thakker, L.H. Jacobson, R. Yamamoto, K. Mitsukawa, R. Maier, F. Natt, D. Husken, P.H. Kelly, K.H. McAllister, D. Hoyer, H. van der Putten, J.F. Cryan, and P.J. Flor mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity Mol. Psychiatry 13 2008 970 979
24. F.A. Fesler Valproate in combat-related posttraumatic stress disorder J. Clin. Psychiatry 52 1991 361 364
25. E.B. Foa, M.R. Liebowitz, M.J. Kozak, S. Davies, R. Campeas, M.E. Franklin, J.D. Huppert, K. Kjernisted, V. Rowan, A.B. Schmidt, H.B. Simpson, and X. Tu Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder Am. J. Psychiatry 162 2005 151 161
26. A. Fontan-Lozano, R. Romero-Granados, J. Troncoso, A. Munera, J.M. Delgado-Garcia, and A.M. Carrion Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice Mol. Cell Neurosci. 39 2008 193 201
27. G. Franklin, and K. Paxinos The Mouse Brain in Stereotaxic Coordinates 2008 Academic Press London
28. W.K. Goodman, K.D. Foote, B.D. Greenberg, N. Ricciuti, R. Bauer, H. Ward, N.A. Shapira, S.S. Wu, C.L. Hill, S.A. Rasmussen, and M.S. Okun Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design Biol. Psychiatry 67 2010 535 542
29. B.M. Graham, J.M. Langton, and R. Richardson Pharmacological enhancement of fear reduction: preclinical models Br. J. Pharmacol. 2010
30. J.E. Grant, B.L. Odlaug, and S.R. Chamberlain Neurocognitive response to deep brain stimulation for obsessive-compulsive disorder: a case report Am. J. Psychiatry 168 2011 1338 1339
31. B.D. Greenberg, L.A. Gabriels, D.A. Malone Jr.; A.R. Rezai, G.M. Friehs, M.S. Okun, N.A. Shapira, K.D. Foote, P.R. Cosyns, C.S. Kubu, P.F. Malloy, S.P. Salloway, J.E. Giftakis, M.T. Rise, A.G. Machado, K.B. Baker, P.H. Stypulkowski, W.K. Goodman, S.A. Rasmussen, and B.J. Nuttin Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience Mol. Psychiatry 15 2010 64 79
32. C. Grubert, R. Hurlemann, B.H. Bewernick, S. Kayser, B. Hadrysiewicz, N. Axmacher, V. Sturm, and T.E. Schlaepfer Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation World J. Biol. Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 12 2011 516 527
33. J.S. Guan, S.J. Haggarty, E. Giacometti, J.H. Dannenberg, N. Joseph, J. Gao, T.J. Nieland, Y. Zhou, X. Wang, R. Mazitschek, J.E. Bradner, R.A. DePinho, R. Jaenisch, and L.H. Tsai HDAC2 negatively regulates memory formation and synaptic plasticity Nature 459 2009 55 60
34. M.B. Hamner, R.A. Faldowski, S. Robert, H.G. Ulmer, M.D. Horner, and J.P. Lorberbaum A preliminary controlled trial of divalproex in posttraumatic stress disorder Ann. Clin. Psychiatry 21 2009 89 94
35. T. Haralambous, and R.F. Westbrook An infusion of bupivacaine into the nucleus accumbens disrupts the acquisition but not the expression of contextual fear conditioning Behav. Neurosci. 113 1999 925 940
36. J.A. Harris, and R.F. Westbrook Evidence that GABA transmission mediates context-specific extinction of learned fear Psychopharmacology (Berl) 140 1998 105 115
37. K. Hefner, N. Whittle, J. Juhasz, M. Norcross, R.M. Karlsson, L.M. Saksida, T.J. Bussey, N. Singewald, and A. Holmes Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain J. Neurosci. 28 2008 8074 8085
38. C. Herry, F. Ferraguti, N. Singewald, J.J. Letzkus, I. Ehrlich, and A. Luthi Neuronal circuits of fear extinction Eur. J. Neurosci. 31 2010 599 612
39. Y. Humeau, D. Reisel, A.W. Johnson, T. Borchardt, V. Jensen, C. Gebhardt, V. Bosch, P. Gass, D.M. Bannerman, M.A. Good, O. Hvalby, R. Sprengel, and A. Luthi A pathway-specific function for different AMPA receptor subunits in amygdala long-term potentiation and fear conditioning J. Neurosci. 27 2007 10947 10956
40. S.A. Josselyn, W.A. Falls, J.C. Gewirtz, P. Pistell, and M. Davis The nucleus accumbens is not critically involved in mediating the effects of a safety signal on behavior Neuropsychopharmacology 30 2005 17 26
41. N.N. Karpova, A. Pickenhagen, J. Lindholm, E. Tiraboschi, N. Kulesskaya, A. Agustsdottir, H. Antila, D. Popova, Y. Akamine, R. Sullivan, R. Hen, L.J. Drew, and E. Castren Fear erasure in mice requires synergy between antidepressant drugs and extinction training Science 334 2011 1731 1734
42. A.G. Kazantsev, and L.M. Thompson Therapeutic application of histone deacetylase inhibitors for central nervous system disorders Nat. Rev. Drug Discov. 7 2008 854 868
43. P.E. Keck Jr.; V.E. Taylor, K.C. Tugrul, S.L. McElroy, and J.A. Bennett Valproate treatment of panic disorder and lactate-induced panic attacks Biol. Psychiatry 33 1993 542 546
44. N. Khan, M. Jeffers, S. Kumar, C. Hackett, F. Boldog, N. Khramtsov, X. Qian, E. Mills, S.C. Berghs, N. Carey, P.W. Finn, L.S. Collins, A. Tumber, J.W. Ritchie, P.B. Jensen, H.S. Lichenstein, and M. Sehested Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors Biochem. J. 409 2008 581 589
45. M. Kilgore, C.A. Miller, D.M. Fass, K.M. Hennig, S.J. Haggarty, J.D. Sweatt, and G. Rumbaugh Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease Neuropsychopharmacology 35 2010 870 880
46. G. Kinrys, M.H. Pollack, N.M. Simon, J.J. Worthington, A.E. Nardi, and M. Versiani Valproic acid for the treatment of social anxiety disorder Int. Clin. Psychopharmacol. 18 2003 169 172
47. G.Y. Ko, L.M. Brown-Croyts, and T.J. Teyler The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the rat hippocampus Brain Res. Bull. 42 1997 297 302
48. O.H. Kramer, P. Zhu, H.P. Ostendorff, M. Golebiewski, J. Tiefenbach, M.A. Peters, B. Brill, B. Groner, I. Bach, T. Heinzel, and M. Gottlicher The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 EMBO J. 22 2003 3411 3420
49. K. Kuriyama, M. Honma, T. Soshi, T. Fujii, and Y. Kim Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial Psychopharmacology (Berl) 218 2011 589 597
50. K.M. Lattal, R.M. Barrett, and M.A. Wood Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction Behav. Neurosci. 121 2007 1125 1131
51. L. Ledgerwood, R. Richardson, and J. Cranney Effects of D-cycloserine on extinction of conditioned freezing Behav. Neurosci. 117 2003 341 349
52. S. Lee, T. Ahmed, H. Kim, S. Choi, D.S. Kim, S.J. Kim, J. Cho, and H.S. Shin Bidirectional modulation of fear extinction by mediodorsal thalamic firing in mice Nat. Neurosci. 15 2011 308 314
53. J.M. Levenson, K.J. O'Riordan, K.D. Brown, M.A. Trinh, D.L. Molfese, and J.D. Sweatt Regulation of histone acetylation during memory formation in the hippocampus J. Biol. Chem. 279 2004 40545 40559
54. L. Levita, J.W. Dalley, and T.W. Robbins Nucleus accumbens dopamine and learned fear revisited: a review and some new findings Behav. Brain Res. 137 2002 115 127
55. S. Li, Y. Murakami, M. Wang, K. Maeda, and K. Matsumoto The effects of chronic valproate and diazepam in a mouse model of posttraumatic stress disorder Pharmacol. Biochem. Behav. 85 2006 324 331
56. X. Li, E.L. Gardner, and Z.X. Xi The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats Neuropharmacology 54 2008 542 551
57. H.C. Lin, S.C. Mao, and P.W. Gean Block of gamma-aminobutyric acid-a receptor insertion in the amygdala impairs extinction of conditioned fear Biol. Psychiatry 66 2009 665 673
58. N. Lipsman, J.S. Neimat, and A.M. Lozano Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target Neurosurgery 61 2007 1 11 discussion 11-13
59. R. Martin, T. Durroux, F. Ciruela, M. Torres, J.P. Pin, and J. Sanchez-Prieto The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals J. Biol. Chem. 285 2010 17907 17917
60. C.B. McCracken, and A.A. Grace High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo J. Neurosci. 27 2007 12601 12610
61. C.B. McCracken, and A.A. Grace Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo J. Neurosci. 29 2009 5354 5363
62. J.L. McGaugh Memory-a century of consolidation Science 287 2000 248 251
63. C.C. McIntyre, M. Savasta, B.L. Walter, and J.L. Vitek How does deep brain stimulation work? Present understanding and future questions J. Clin. Neurophysiol.: Official Publication of the American Electroencephalographic Society 21 2004 40 50
64. S.C. McQuown, R.M. Barrett, D.P. Matheos, R.J. Post, G.A. Rogge, T. Alenghat, S.E. Mullican, S. Jones, J.R. Rusche, M.A. Lazar, and M.A. Wood HDAC3 is a critical negative regulator of long-term memory formation J. Neurosci. 31 2011 764 774
65. M.R. Milad, R.K. Pitman, C.B. Ellis, A.L. Gold, L.M. Shin, N.B. Lasko, M.A. Zeidan, K. Handwerger, S.P. Orr, and S.L. Rauch Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder Biol. Psychiatry 66 2009 1075 1082
66. C. Millan, R. Lujan, R. Shigemoto, and J. Sanchez-Prieto The inhibition of glutamate release by metabotropic glutamate receptor 7 affects both [Ca2+]c and cAMP: evidence for a strong reduction of Ca2+ entry in single nerve terminals J. Biol. Chem. 277 2002 14092 14101
67. L.G. Miller, D.J. Greenblatt, J.G. Barnhill, W.R. Summer, and R.I. Shader 'GABA shift' in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA Eur. J. Pharmacol. 148 1988 123 130
68. T. Mimaki, H. Yabuuchi, H. Laird, and H.I. Yamamura Effects of seizures and antiepileptic drugs on benzodiazepine receptors in rat brain Pediatr. Pharmacol. (New York) 4 1984 205 211
69. K. Mitsukawa, R. Yamamoto, S. Ofner, J. Nozulak, O. Pescott, S. Lukic, N. Stoehr, C. Mombereau, R. Kuhn, K.H. McAllister, H. van der Putten, J.F. Cryan, and P.J. Flor A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo Proc. Natl. Acad. Sci. U S A 102 2005 18712 18717
70. M.S. Monsey, K.T. Ota, I.F. Akingbade, E.S. Hong, and G.E. Schafe Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala PLoS One 6 2011 e19958
71. K.M. Myers, and M. Davis Mechanisms of fear extinction Mol. Psychiatry 12 2007 120 150
72. K.M. Myers, W.A. Carlezon Jr.; and M. Davis Glutamate receptors in extinction and extinction-based therapies for psychiatric illness Neuropsychopharmacology 36 2011 274 293
73. M.M. Norberg, J.H. Krystal, and D.F. Tolin A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy Biol. Psychiatry 63 2008 1118 1126
74. L.G. Nowak, and J. Bullier Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. I. Evidence from chronaxie measurements Exp. Brain Res. 118 1998 477 488
75. L.G. Nowak, and J. Bullier Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments Exp. Brain Res. 118 1998 489 500
76. D.J. Nutt Overview of diagnosis and drug treatments of anxiety disorders CNS Spectr. 10 2005 49 56
77. R.M. O'Connor, B.C. Finger, P.J. Flor, and J.F. Cryan Metabotropic glutamate receptor 7: at the interface of cognition and emotion Eur. J. Pharmacol. 639 2010 123 131
78. H. Ohishi, S. Nomura, Y.Q. Ding, R. Shigemoto, E. Wada, A. Kinoshita, J.L. Li, A. Neki, S. Nakanishi, and N. Mizuno Presynaptic localization of a metabotropic glutamate receptor, mGluR7, in the primary afferent neurons: an immunohistochemical study in the rat Neurosci. Lett. 202 1995 85 88
79. M.S. Okun, G. Mann, K.D. Foote, N.A. Shapira, D. Bowers, U. Springer, W. Knight, P. Martin, and W.K. Goodman Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming J. Neurol. Neurosurg. Psychiatry 78 2007 310 314
80. J. Olesen, A. Gustavsson, M. Svensson, H.U. Wittchen, and B. Jonsson The economic cost of brain disorders in Europe Eur. J. Neurol.: the Official Journal of the European Federation of Neurological Societies 19 2012 155 162
81. C.A. Orsini, and S. Maren Neural and cellular mechanisms of fear and extinction memory formation Neurosci. Biobehav. Rev. 2012
82. C. Otte, K. Wiedemann, A. Yassouridis, and M. Kellner Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study J. Clin. Psychopharmacol. 24 2004 106 108
83. H.C. Pape, and D. Pare Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear Physiol. Rev. 90 2010 419 463
84. S. Peleg, F. Sananbenesi, A. Zovoilis, S. Burkhardt, S. Bahari-Javan, R.C. Agis-Balboa, P. Cota, J.L. Wittnam, A. Gogol-Doering, L. Opitz, G. Salinas-Riester, M. Dettenhofer, H. Kang, L. Farinelli, W. Chen, and A. Fischer Altered histone acetylation is associated with age-dependent memory impairment in mice Science 328 2010 753 756
85. F. Primeau, R. Fontaine, and L. Beauclair Valproic acid and panic disorder Can. journal Psychiatry Revue Canadienne De Psychiatrie 35 1990 248 250
86. G.J. Quirk, and D. Mueller Neural mechanisms of extinction learning and retrieval Neuropsychopharmacology 33 2008 56 72
87. K.J. Ressler, B.O. Rothbaum, L. Tannenbaum, P. Anderson, K. Graap, E. Zimand, L. Hodges, and M. Davis Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear Arch. Gen. Psychiatry 61 2004 1136 1144
88. R. Richardson, L. Ledgerwood, and J. Cranney Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications Learn. Mem. 11 2004 510 516
89. G. Riedel, N.R. Harrington, G. Hall, and E.M. Macphail Nucleus accumbens lesions impair context, but not cue, conditioning in rats Neuroreport 8 1997 2477 2481
90. J. Rodriguez-Romaguera, F.H. Do Monte, and G.J. Quirk Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear Proc. Natl. Acad. Sci. U S A 2012
91. D.D. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J. Pharmacol. Exp. Ther. 299 2001 12 20
92. N.A. Shapira, M.S. Okun, D. Wint, K.D. Foote, J.A. Byars, D. Bowers, U.S. Springer, P.J. Lang, B.D. Greenberg, S.N. Haber, and W.K. Goodman Panic and fear induced by deep brain stimulation J. Neurol. Neurosurg. Psychiatry 77 2006 410 412
93. S. Siegl, P.J. Flor, and M. Fendt Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear Neuroreport 19 2008 1147 1150
94. M.V. Simonini, L.M. Camargo, E. Dong, E. Maloku, M. Veldic, E. Costa, and A. Guidotti The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases Proc. Natl. Acad. Sci. U S A 103 2006 1587 1592
95. F. Soliman, C.E. Glatt, K.G. Bath, L. Levita, R.M. Jones, S.S. Pattwell, D. Jing, N. Tottenham, D. Amso, L.H. Somerville, H.U. Voss, G. Glover, D.J. Ballon, C. Liston, T. Teslovich, T. Van Kempen, F.S. Lee, and B.J. Casey A genetic variant BDNF polymorphism alters extinction learning in both mouse and human Science 327 2010 863 866
96. F. Sotres-Bayon, D.E. Bush, and J.E. LeDoux Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala Neuropsychopharmacology 32 2007 1929 1940
97. J.M. Stafford, J.D. Raybuck, A.E. Ryabinin, and K.M. Lattal, Increasing histone acetylation in the hippocampus-infralimbic network enhances fear extinction Biol. Psychiatry. 72 1 2012 25 33
98. T. Steckler, and V. Risbrough Pharmacological treatment of PTSD - established and new approaches Neuropharmacology 2011
99. S.J. Sukoff Rizzo, S.K. Leonard, A. Gilbert, P. Dollings, D.L. Smith, M.Y. Zhang, L. Di, B.J. Platt, S. Neal, J.M. Dwyer, C.N. Bender, J. Zhang, T. Lock, D. Kowal, A. Kramer, A. Randall, C. Huselton, K. Vishwanathan, S.Y. Tse, J. Butera, R.H. Ring, S. Rosenzweig-Lipson, Z.A. Hughes, and J. Dunlop The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise? J. Pharmacol. Exp. Ther. 338 2011 345 352
100. J.D. Sweatt Mitogen-activated protein kinases in synaptic plasticity and memory Curr. Opin. Neurobiol. 14 2004 311 317
101. L. Tremolizzo, M.S. Doueiri, E. Dong, D.R. Grayson, J. Davis, G. Pinna, P. Tueting, V. Rodriguez-Menendez, E. Costa, and A. Guidotti Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice Biol. Psychiatry 57 2005 500 509
102. N.C. Tronson, K.A. Corcoran, V. Jovasevic, and J. Radulovic Fear conditioning and extinction: emotional states encoded by distinct signaling pathways Trends Neurosci. 35 2012 145 155
103. A. van Dijk, O. Mason, A.A. Klompmakers, M.G. Feenstra, and D. Denys Unilateral deep brain stimulation in the nucleus accumbens core does not affect local monoamine release J. Neurosci. Methods 202 2011 113 118
104. D.L. Walker, and M. Davis The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction Pharmacol. Biochem. Behav. 71 2002 379 392
105. N. Whittle, M. Hauschild, G. Lubec, A. Holmes, and N. Singewald Rescue of impaired fear extinction and normalization of cortico-amygdala circuit dysfunction in a genetic mouse model by dietary zinc restriction J. Neurosci. 30 2010 13586 13596
106. C.L. Woodman, and R. Noyes Jr. Panic disorder: treatment with valproate J. Clin. Psychiatry 55 1994 134 136
107. D. Yamada, K. Zushida, K. Wada, and M. Sekiguchi Pharmacological discrimination of extinction and reconsolidation of contextual fear memory by a potentiator of AMPA receptors Neuropsychopharmacology 34 2009 2574 2584
108. R. Yehuda, and J. LeDoux Response variation following trauma: a translational neuroscience approach to understanding PTSD Neuron 56 2007 19 32
109. K. Zushida, M. Sakurai, K. Wada, and M. Sekiguchi Facilitation of extinction learning for contextual fear memory by PEPA: a potentiator of AMPA receptors J. Neurosci. 27 2007 158 166